- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04589195
Measuring Mindfulness Application
January 12, 2022 updated by: Amishi Jha, University of Miami
Measurement of an Application - Based Delivery of Mindfulness Training Program Content
The purpose of the research study is to learn more about how ROTC cadets may engage with mindfulness training program content that is delivered through a smartphone or website application.
Mindfulness training program content includes mindfulness practices that foster attention and awareness.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
44
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Coral Gables, Florida, United States, 33146
- University of Miami
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 64 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Individuals who are between 18 and 64 years of age.
- Individuals who are fluent English speakers.
- Individuals who have access to either an Apple or Android smart phone and a desktop or laptop computer, are able to adequately and independently use both devices, and have Internet connection.
- Individuals who are willing and able to consent to participate in the study.
- Individuals who are in the South Florida ROTC program.
Exclusion Criteria:
1.Individuals with an active and untreated mental condition (e.g., Bipolar disorder, Major Depression) and/or hospitalization for psychological/mental health issues within the last month.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Mindfulness Training (MT) Group
Participants will receive four weeks of MT.
|
The intervention includes four weeks of MT application use, accessed via phone or computer, consisting of 15-minute daily mindfulness practices 5 days a week.
|
|
ACTIVE_COMPARATOR: Wait List MT Group
Participants will receive four weeks of MT training after a five week washout period.
|
The intervention includes four weeks of MT application use, accessed via phone or computer, consisting of 15-minute daily mindfulness practices 5 days a week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Positive Affect
Time Frame: Baseline to Week 5
|
Positive affect will be measured with the 10-item version of the Positive and Negative Affect Schedule (PANAS-10).
The PANAS positive sub-scale has 5 items and a range of scores from 5 to 25, with a higher score indicating a higher positive mood.
|
Baseline to Week 5
|
|
Change in Negative Affect
Time Frame: Baseline to Week 5
|
Negative affect will be measured with the 10-item version of the Positive and Negative Affect Schedule (PANAS-10).
The PANAS negative sub-scale has 5 items and a range of scores from 5 to 25, with a higher score indicating a higher negative mood.
|
Baseline to Week 5
|
|
Change in Perceived Stress
Time Frame: Baseline to Week 5
|
Perceived Stress will be measured with the Perceived Stress Scale (PSS).
PSS has a range of scores from 0 to 40, with a higher score indicates a higher level of perceived stress.
|
Baseline to Week 5
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Sustained Attention Response Task (SART) scores
Time Frame: Baseline to Week 5
|
The SART involves pressing a button to frequently presented non-target trials and withholding the button press to the infrequent target trials.
The participants can have a total score between 0 and 100%, with a higher score indicating butter sustained attention.
|
Baseline to Week 5
|
|
Change in Cognitive Failures
Time Frame: Baseline to Week 5
|
Cognitive Failures will be measured with the Cognitive Failures Questionnaire (CFQ).
CFQ has a range of scores from 0 to 100, with a higher score indicating more cognitive failures.
|
Baseline to Week 5
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Psychological Health
Time Frame: Baseline to Week 5
|
Patient Health Questionnaire (PHQ4) will be used to assess depression and anxiety.
PHQ has a range of scores from 0 to 12, with a higher score indicating higher level of depression and anxiety.
|
Baseline to Week 5
|
|
Change in Mindfulness
Time Frame: Baseline to Week 5
|
Mindfulness will be measured with the short 15-item version of the Five-Facet Mindfulness Questionnaire (FFMQ-15).
FFMQ-15 has a range of scores from 15 to 75, with a higher score indicating a greater level of mindfulness.
|
Baseline to Week 5
|
|
Change in Decentering
Time Frame: Baseline to Week 5
|
Decentering will be measured with the decentering scale from the Experience Questionnaire (EQ-D).
EQ-D has a range of scores from 11 to 55, with a higher score indicating a greater level of decentering.
|
Baseline to Week 5
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Amishi Jha, PhD, University of Miami
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
October 11, 2021
Primary Completion (ACTUAL)
November 29, 2021
Study Completion (ACTUAL)
December 26, 2021
Study Registration Dates
First Submitted
October 9, 2020
First Submitted That Met QC Criteria
October 9, 2020
First Posted (ACTUAL)
October 19, 2020
Study Record Updates
Last Update Posted (ACTUAL)
January 14, 2022
Last Update Submitted That Met QC Criteria
January 12, 2022
Last Verified
January 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- 20201140
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cognitive Change
-
University Ramon LlullAinhoa Nieto Guisado; Mònica Solana-TramuntUnknownCognitive Change | Proprioception Change | Balance ChangeSpain
-
Applied Science & Performance InstituteCompletedCognitive Change | Mood Change | Mental ProcessesUnited States
-
National Council of Scientific and Technical Research...CompletedSleep | Cognitive Change | Mood Change | CreativityArgentina
-
Heilongjiang Feihe Dairy Co. Ltd.CompletedCognitive ChangeChina
-
University of MiamiMcKnight Brain Research FoundationCompleted
-
University of Wisconsin, MadisonNational Institute on Aging (NIA); University of California, Irvine; University...Completed
-
Tufts UniversityCompleted
-
Northeastern UniversityNational Institute on Aging (NIA); University of California, RiversideCompletedCognitive ChangeUnited States
-
Western University, CanadaInteraXon, Inc.; Cambridge Brain SciencesCompletedCognitive ChangeCanada
-
University of MiamiUnited States Department of DefenseTerminated
Clinical Trials on Mindfulness Training
-
Yale UniversityCompletedMental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse) | Mental Health Wellness 1 | War-Related TraumaJordan
-
University of California, San DiegoCompleted
-
King's College LondonCompletedAdults With Overweight and ObesityUnited Kingdom
-
University of HoustonCompletedDepression | Stress | Anxiety | Well-beingUnited States
-
Boston University Charles River CampusTerminatedSmoking CessationUnited States
-
Freie Universität BerlinCharite University, Berlin, GermanyCompletedMajor Depressive Disorder
-
The Miriam HospitalCompleted
-
Bayburt UniversityNot yet recruitingFear of Childbirth | Mindfulness | Self-Efficacy | Attachment | Haptonomy
-
Universidad de AntioquiaCompletedHealthy VolunteersColombia